IS TREATMENT-RESISTANCE IN PSYCHIATRIC DISORDERS A TRAP FOR POLYPHARMACY?

Other literature type English OPEN
Jašović-Gašić, Miroslava;
(2015)

Background: Nowadays, more and more mental health professionals manage patients who fail treatment for major psychiatric disorders. There is not a consensus on how to deal with treatment-resistance patients, but usually psychiatrists result to polypharmacy. Met... View more
  • References (54)
    54 references, page 1 of 6

    1. Arnedo J, Svrakic DM, Del Val C, Romero-Zaliz R, Hernández-Cuervo H; Molecular Genetics of Schizophrenia Consortium, Fanous AH, Pato MT, Pato CN, de Erausquin GA, Cloninger CR, Zwir I: Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. Am J Psychiatry. 2015; 172:139-153.

    2. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino PR, Keller W: Schizophrenia Patient Outcomes Research Team (PORT): The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010; 36:71-93.

    3. Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B: Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry 2001; 158:518-526.

    4. Cole JO, Goldberg SC, and Davis JM: Drugs in the treatment of psychosis: controlled studies. In: Solomon T, ed. Psychiatric Drugs. New York, NY: Grollerand Stratton, 1966, pp153-180.

    5. Coldwell CM, Bender WS: The effectiveness of assertive community treatment for homeless populations with severe mental illness: a meta-analysis. Am J Psychiatry 2007; 164:393.

    6. Demjaha A, Murray RM, McGuire PK, Kapur S, Howes OD: Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry. 2012; 169:1203-1210.

    7. Divac N, Jasović-Gasić M, Samardzić R, Lacković M, Prostran: Antipsychotic polypharmacy at the University Psychiatric Hospital in Serbia. Pharmacoepidemiol Drug Saf 2007; 16:1250-1251.

    8. Dlabac-de Lange JJ, Knegtering R, Aleman A: Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry 2010; 71:411.

    9. Dold M, Li C, Tardy M, Khorsand V, Gillies D, Leucht S: Benzodiazepines for schizophrenia. Cochrane Database Syst Rev 2012; 11:CD006391.

    10. Dold M & Leucht S: Pharmacotherapy of treatmentresistant schizophrenia: a clinical perspective. Evid Based Ment Health 2014; 17:33-37.

  • Related Organizations (2)
  • Metrics
Share - Bookmark